Towards an economic evidence base for pharmacogenetics: Consideration of outcomes in key

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)1-4
    Number of pages3
    JournalPharmacogenomics
    Volume9
    Issue number1
    DOIs
    Publication statusPublished - Jan 2008

    Keywords

    • Cost-Benefit Analysis
    • Databases, Factual
    • Decision Making, Organizational
    • Evidence-Based Medicine
    • Great Britain
    • economics: Health Resources
    • Humans
    • genetics: Methyltransferases
    • economics: Pharmacogenetics
    • Quality-Adjusted Life Years
    • Treatment Outcome

    Cite this